Time trends of surgical outcome in patients with non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 6, 2010, Pages 825-829

  Hanagiri, Takeshi ^a   Baba, Tetsuro ^a   So, Tetsuya ^a   Yasuda, Manabu ^a   Sugaya, Masakazu ^a   Ono, Kenji ^a   So, Tomoko ^a   Uramoto, Hidetaka ^a   Takenoyama, Mitsuhiro ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Non small cell lung cancer; Surgical outcome; Surgical resection; Time trend

Indexed keywords

CARBOPLATIN; GEMCITABINE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EARLY DIAGNOSIS; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; AGE; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY;

AGE FACTORS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953134174     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d5e47f     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592.
3. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005;172:523-529.
4. Okada M, Nishio W, Sakamoto T, et al. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg 2004;77:1926-1930.
5. Seki N, Sawada S, Nakata M, et al. Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers. J Thorac Oncol 2008;3:483-490.
6. Roy MS, Donington JS. Management of locally advanced non small cell lung cancer from a surgical perspective. Curr Treat Options Oncol 2007;8:1-14.
7. Casali C, Stefani A, Natali P, et al. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 2005;28:33-38.
8. Lee JG, Lee CY, Kim DJ, et al. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment. Eur J Cardiothorac Surg 2008;33:480-484.
9. Travis WD, Colby TV, Corrin B, et al. (Eds.) Histological Type of Lung and Pleural Tumors. World Health Organization International Histological Classification of Tumors, 3rd Ed. Berlin: Springer, 1999.
10. Sobin LH, Wittekind CH. (Eds.) TNM Classification of Malignant Tumours, 6th Ed. New York: Wiley-Liss, 2002. Pp. 97-103.
11. Wahidi MM, Govert JA, Goudar RK, et al; American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:94S-107S.
12. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005;23:3279-3287.
13. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299.
14. Raz DJ, He B, Rosell R, et al. Bronchioloalveolar carcinoma: a review. Clin Lung Cancer 2006;7:313-322.
15. Goya T, Asamura H, Yoshimura H, et al; The Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005;50:227-234.
16. Asamura H, Goya T, Koshiishi Y, et al; Japanese Joint Committee of Lung Cancer Registry. A Japanese Lung Cancer Registry study: prognosis of 13, 010 resected lung cancers. J Thorac Oncol 2008;3:46-52.
17. Roberts HC, Patsios D, Paul NS, et al. Lung cancer screening with low-dose computed tomography: Canadian experience. Can Assoc Radiol J 2007;58:225-235. (Pubitemid 350021946)
18. Kawachi R, Watanabe S, Asamura H. Clinicopathological characteristics of screen-detected lung cancers. J Thorac Oncol 2009;4:615-619.
19. Hanagiri T, Sugio K, Mizukami M, et al. Postoperative prognosis in patients with non-small cell lung cancer according to the method of initial detection. J Thorac Oncol 2007;2:907-911.
20. Arriagada R, Bergman B, Dunant A, et al; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-360.
21. Winton T, Livingston R, Johnson D, et al; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR. 10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597.
22. Pignon JP, Tribodet H, Scagliotti GV, et al; LACE Collaborative Group. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-3559.
23. NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 2008;26:4617-4625.
24. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
25. Sugio K, Uramoto H, Onitsuka T, et al. Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations. Lung Cancer 2009;64:314-318.
26. Costa DB, Kobayashi S, Tenen DG, et al. Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. Lung Cancer 2007;58:95-103.
27. Hanagiri T, Muranaka H, Hashimoto M, et al. Results of surgical treatment of lung cancer in octogenarians. Lung Cancer 1999;23:129-133.
28. Okami J, Higashiyama M, Asamura H, et al; Japanese Joint Committee of Lung Cancer Registry. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009 July 15 [Epub ahead of print].